Issued Patents All Time
Showing 1–21 of 21 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12226416 | Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality | Karl A. Nath, James L. Kirkland | 2025-02-18 |
| 11980616 | Treating liver disease by selectively eliminating senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +1 more | 2024-05-14 |
| 11925640 | Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality | Karl A. Nath, James L. Kirkland | 2024-03-12 |
| 11517572 | Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid | James L. Kirkland, Yi Zhu, Allyson K. Palmer, Nathan K. LeBrasseur, Jordan D. Miller | 2022-12-06 |
| 11351167 | Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, James L. Kirkland +3 more | 2022-06-07 |
| 10517866 | Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor | Remi-Martin Laberge, James L. Kirkland, Yi Zhu, Nathaniel David, Alain P. Vasserot +3 more | 2019-12-31 |
| 10478432 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-11-19 |
| 10478433 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Darren J. Baker +5 more | 2019-11-19 |
| 10413542 | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase | Remi-Martin Laberge, Nathaniel David, Alain P. Vasserot, Darren J. Baker, Bennett G. Childs +3 more | 2019-09-17 |
| 10328073 | Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2019-06-25 |
| 10328058 | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques | Darren J. Baker, Marco Demaria, Albert Davalos, Bennett G. Childs, Jan M.A. van Deursen +5 more | 2019-06-25 |
| 10258618 | Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Darren J. Baker +3 more | 2019-04-16 |
| 10251376 | Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells | James L. Kirkland, Jan M.A. van Deursen, Darren J. Baker | 2019-04-09 |
| 10213426 | Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population | Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Nathaniel David +2 more | 2019-02-26 |
| 10130628 | Treatment of joint pain | Nathaniel David, Albert Davalos, Remi-Martin Laberge, Judith Campisi, Marco Demaria +6 more | 2018-11-20 |
| 10010546 | Treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +5 more | 2018-07-03 |
| 9993472 | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 | Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Nathaniel David +7 more | 2018-06-12 |
| 9980962 | Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Darren J. Baker +3 more | 2018-05-29 |
| 9968076 | Transgenic animals capable of being induced to delete senescent cells | James L. Kirkland, Jan M.A. van Deursen, Darren J. Baker | 2018-05-15 |
| 9855266 | Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline | Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Nathaniel David +6 more | 2018-01-02 |
| 9849128 | Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells | Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Nathaniel David +6 more | 2017-12-26 |